688076 诺泰生物
已收盘 12-20 15:00:01
资讯
新帖
简况
诺泰生物：公司新增借款是基于企业经营需要所产生的，主要用于公司日常经营等
证券之星 · 12-19 19:00
诺泰生物：公司新增借款是基于企业经营需要所产生的，主要用于公司日常经营等
诺泰生物12月17日获主力加仓1327万元 环比增加503.18%
市场透视 · 12-17
诺泰生物12月17日获主力加仓1327万元 环比增加503.18%
诺泰生物：公司与美国斯普瑞喷雾系统公司签署战略合作意向书
中国财富通 · 12-09
诺泰生物：公司与美国斯普瑞喷雾系统公司签署战略合作意向书
诺泰生物(688076.SH)与SSC就静电喷雾干燥技术应用于多肽原料药商业化生产领域达成战略合作
智通财经网 · 12-08
诺泰生物(688076.SH)与SSC就静电喷雾干燥技术应用于多肽原料药商业化生产领域达成战略合作
诺泰生物最新公告：与美国斯普瑞喷雾系统公司签订战略合作意向书
证券之星 · 12-08
诺泰生物最新公告：与美国斯普瑞喷雾系统公司签订战略合作意向书
诺泰生物（688076）12月2日主力资金净买入6331.87万元
证券之星 · 12-03
诺泰生物（688076）12月2日主力资金净买入6331.87万元
诺泰生物12月02日收跌3.69% 主力资金逆市抢筹
市场透视 · 12-02
诺泰生物12月02日收跌3.69% 主力资金逆市抢筹
诺泰生物跌5% 3券商增持
智选洞察 · 12-02
诺泰生物跌5% 3券商增持
诺泰生物11月29日遭主力抛售1065万元 环比增加379.73%
市场透视 · 11-29
诺泰生物11月29日遭主力抛售1065万元 环比增加379.73%
1-10月医保统筹收入稳增长，机构：医药后市反转源于三大机会
汇添富基金 · 11-28
1-10月医保统筹收入稳增长，机构：医药后市反转源于三大机会
诺泰生物11月27日主力资金流入355万元 连续3日加仓
市场透视 · 11-27
诺泰生物11月27日主力资金流入355万元 连续3日加仓
A股减肥药板块盘初活跃，昊帆生物涨超10%，诺泰生物、华森制药涨超4%，恒瑞医药、信立泰、百花医药等跟涨。
美港电讯 · 11-27
A股减肥药板块盘初活跃，昊帆生物涨超10%，诺泰生物、华森制药涨超4%，恒瑞医药、信立泰、百花医药等跟涨。
诺泰生物司美格鲁肽注射液Ⅲ期临床全国研究者会在宁召开
新华日报财经 · 11-26
诺泰生物司美格鲁肽注射液Ⅲ期临床全国研究者会在宁召开
诺泰生物跌5% 3券商增持
智选洞察 · 11-22
诺泰生物跌5% 3券商增持
概念掘金 | 司美格鲁肽减肥药正式在中国上市，多家电商平台已上线
格隆汇 · 11-17
概念掘金 | 司美格鲁肽减肥药正式在中国上市，多家电商平台已上线
诺泰生物大幅上涨 生物医药产业蓬勃发展
智选洞察 · 11-12
诺泰生物大幅上涨 生物医药产业蓬勃发展
11月11日诺泰生物涨7.04%，南方医药保健灵活配置混合A基金重仓该股
证券之星 · 11-11
11月11日诺泰生物涨7.04%，南方医药保健灵活配置混合A基金重仓该股
诺泰生物涨7.04%，国金证券二周前给出“买入”评级
证券之星 · 11-11
诺泰生物涨7.04%，国金证券二周前给出“买入”评级
诺泰生物11月11日收涨7.04% 主力资金逆市抛售
市场透视 · 11-11
诺泰生物11月11日收涨7.04% 主力资金逆市抛售
诺泰生物大幅上涨 青海省医保局调整检验类项目价格
智选洞察 · 11-11
诺泰生物大幅上涨 青海省医保局调整检验类项目价格
暂无数据
公司概况
公司名称：
江苏诺泰澳赛诺生物制药股份有限公司
所属行业：
医药制造业
上市日期：
2021-05-20
主营业务：
江苏诺泰澳赛诺生物制药股份有限公司是一家聚焦多肽药物及小分子化药进行自主研发与定制研发生产相结合的生物医药企业。公司的主要产品为阿托伐他汀钙片、氨氯地平阿托伐他汀钙片、利拉鲁肽、司美格鲁肽、苯甲酸阿格列汀、比伐芦定、依替巴肽、醋酸兰瑞肽、醋酸奥曲肽、磷酸奥司他韦、胸腺法新、GLP-1/GIP/GCG受体多靶点激动剂1类新药、氟维司群。
发行价格：
15.57
{"stockData":{"symbol":"688076","market":"SH","secType":"STK","nameCN":"诺泰生物","latestPrice":50.41,"timestamp":1734678001000,"preClose":52.01,"halted":0,"volume":4423446,"delay":0,"floatShares":220000000,"shares":220000000,"eps":1.9177,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.6,"latestTime":"12-20 15:00:01","open":51.99,"high":52.05,"low":50.01,"amount":224000000,"amplitude":0.0392,"askPrice":50.42,"askSize":266,"bidPrice":50.41,"bidSize":1,"shortable":0,"etf":0,"ttmEps":1.9177,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":52.01,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":57.21,"lowLimit":46.81,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":219779883,"pbRate":4.35,"roa":"--","roe":"14.63%","epsLYR":0.76,"committee":0.256466,"marketValue":11079000000,"floatMarketCap":11079000000,"peRate":26.286697,"changeRate":-0.0308,"turnoverRate":0.0201,"status":1,"afterMarket":{"amount":0,"volume":0,"close":50.41,"buyVolume":0,"sellVolume":0,"time":1734680038975,"indexStatus":"已收盘 12-20 15:30:00","preClose":52.01}},"requestUrl":"/m/hq/s/688076/tweets","defaultTab":"tweets","newsList":[{"id":"2492233251","title":"诺泰生物：公司新增借款是基于企业经营需要所产生的，主要用于公司日常经营等","url":"https://stock-news.laohu8.com/highlight/detail?id=2492233251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492233251?lang=zh_cn&edition=full","pubTime":"2024-12-19 19:00","pubTimestamp":1734606052,"startTime":"0","endTime":"0","summary":"公司目前所有债务均按时还本付息，新增借款不会对公司偿债能力产生重大不利影响，谢谢！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121900032029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2492996323","title":"诺泰生物12月17日获主力加仓1327万元 环比增加503.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492996323","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492996323?lang=zh_cn&edition=full","pubTime":"2024-12-17 15:19","pubTimestamp":1734419958,"startTime":"0","endTime":"0","summary":"12月17日, 诺泰生物股价涨2.40%，报收52.00元，成交金额1.79亿元，换手率1.58%，振幅3.62%，量比1.32。诺泰生物今日主力资金净流入1327万元，连续3日净流入，上一交易日主力净流入220万元，今日环比增加503.18%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为33.33%，平均涨幅为2.08%。该股近5个交易日下跌0.95%，主力资金累计净流入593万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入7856万元，其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217153111a1f5256b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217153111a1f5256b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2490711526","title":"诺泰生物：公司与美国斯普瑞喷雾系统公司签署战略合作意向书","url":"https://stock-news.laohu8.com/highlight/detail?id=2490711526","media":"中国财富通","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490711526?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:05","pubTimestamp":1733727901,"startTime":"0","endTime":"0","summary":"中国财富通12月9日 - 诺泰生物公告称，近日，公司与美国斯普瑞喷雾系统公司签署《战略合作意向书》，就静电喷雾干燥技术应用于多肽原料药商业化生产领域达成战略合作。诺泰生物表示，公司始终高度重视科技创新，通过学科交叉保持技术优势和竞争壁垒。此次战略合作旨在通过先进技术的实际落地，为公司多肽大规模生产奠定更扎实的技术和成本优势基础，进一步提升公司在多肽等细分领域的核心竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=wo4%2Bo%2BZfc64%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2489657789","title":"诺泰生物(688076.SH)与SSC就静电喷雾干燥技术应用于多肽原料药商业化生产领域达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2489657789","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489657789?lang=zh_cn&edition=full","pubTime":"2024-12-08 15:52","pubTimestamp":1733644340,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺泰生物 发布公告，近日，公司与美国斯普瑞喷雾系统公司签署了《战略合作意向书》，就静电喷雾干燥技术应用于多肽原料药商业化生产领域达成战略合作。诺泰生物旨在成为行业领先的采用PolarDry静电喷雾干燥技术实现多肽产品商业化生产的企业，大幅提升公司在多肽大规模生产领域的技术和成本优势，为未来十吨级及以上多肽产品的生产奠定坚实基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221840.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2489078993","title":"诺泰生物最新公告：与美国斯普瑞喷雾系统公司签订战略合作意向书","url":"https://stock-news.laohu8.com/highlight/detail?id=2489078993","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489078993?lang=zh_cn&edition=full","pubTime":"2024-12-08 15:51","pubTimestamp":1733644266,"startTime":"0","endTime":"0","summary":"诺泰生物公告，公司近日与美国斯普瑞喷雾系统公司（SSC）签署了《战略合作意向书》，就静电喷雾干燥技术应用于多肽原料药商业化生产领域达成战略合作。SSC是全球领先的工业用喷雾喷嘴和自动喷雾系统的专业制造商，其专利PolarDry®技术具有实现低温高效干燥、保持产品质量和生物活性等优势。双方计划于2027年底前完成约16台设备的供货，公司承诺在协议期间采购约16套设备。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120800001094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2488065938","title":"诺泰生物（688076）12月2日主力资金净买入6331.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488065938","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488065938?lang=zh_cn&edition=full","pubTime":"2024-12-03 08:20","pubTimestamp":1733185245,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月2日收盘，诺泰生物报收于51.96元，下跌3.69%，换手率4.24%，成交量9.32万手，成交额4.84亿元。近5日资金流向一览见下表：诺泰生物融资融券信息显示，融资方面，当日融资买入4571.55万元，融资偿还2252.08万元，融资净买入2319.47万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120300008080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2488623082","title":"诺泰生物12月02日收跌3.69% 主力资金逆市抢筹","url":"https://stock-news.laohu8.com/highlight/detail?id=2488623082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488623082?lang=zh_cn&edition=full","pubTime":"2024-12-02 15:18","pubTimestamp":1733123916,"startTime":"0","endTime":"0","summary":"12月02日, 诺泰生物股价跌3.69%，报收51.96元，成交金额4.84亿元，换手率4.24%，振幅5.06%，量比2.38。诺泰生物今日主力资金净流入6410万元，上一交易日主力净流出1065万元。该股近5个交易日下跌3.42%，主力资金累计净流入5950万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1.08亿元，其中净流入天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202152536abef00d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202152536abef00d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2488861151","title":"诺泰生物跌5% 3券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2488861151","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488861151?lang=zh_cn&edition=full","pubTime":"2024-12-02 09:45","pubTimestamp":1733103946,"startTime":"0","endTime":"0","summary":"12月02日，诺泰生物股价大幅下跌，截至09点45分，诺泰生物下跌5.10%，报51.20元/股，成交1.41亿元，换手率1.23%，振幅5.06%。资金动向截止发稿，诺泰生物获得主力净流出696万元，其中超大单流入750万元，大单流出1446万元。主营业务及业绩诺泰生物公司主营业务为多肽药物及小分子化药进行自主研发与定制研发生产。最新财报显示，今年三季报，诺泰生物实现营业收入12.52亿元，同比增长76.51%，净利润为3.50亿元，同比增长281.90%，基本每股收益为1.62元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202094553abee4e4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202094553abee4e4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2487377584","title":"诺泰生物11月29日遭主力抛售1065万元 环比增加379.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487377584","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487377584?lang=zh_cn&edition=full","pubTime":"2024-11-29 15:20","pubTimestamp":1732864841,"startTime":"0","endTime":"0","summary":"11月29日, 诺泰生物股价涨1.12%，报收53.95元，成交金额1.79亿元，换手率1.51%，振幅3.32%，量比0.81。诺泰生物今日主力资金净流出1065万元，上一交易日主力净流出222万元，今日环比增加379.73%。净流出前三个股分别为三博脑科、盈康生命、诺泰生物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129153812a25e89e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129153812a25e89e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长，机构：医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上，据医保局日前披露，2024年1-10月医保统筹基金收入23065.07亿元，同比增长8.9%；2024年1-10月统筹支出19165.88亿元，同比增长8.9%。对此，国泰君安表示，1-10月医保统筹基金运行平稳，收入稳健增长，支出增速逐月收窄。国金证券表示，由于多方面因素，医药板块景气度在2021年后经历了长时间的下行。2024年11月7日，国家医保局召开了座谈会，强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600721","603108","BK0185","688163","603087","600976","600351","603858","600436","603939","688575","600380","600998","688331","603309","688266","600200","688278","600055","605199","603392","600161","600521","BK0070","600572","688192","688276","603439","600771","688506","688315","603567","600511","BK0096","688298","688356","600329","688193","600332","688581","688180","688336","600851","688076","688139","688198","600196","603127","600085","600129","688656","600080","603301","603658","600566","688373","688189","688067","605177","BK0012","600867","688221","688050","688488","688578","688687","688212","688105","688301","688670","600056","688046","688382","688091","688389","603456","688062","688085","603707","688566","600739","688235","688247","688428","600079","600062","688520","600763","603882","BK0239","688177","159938","603259","600252","603538","603896","688029","600420","688117","688658","688073","688351","BK0188","688222","688137","601607","688202","603590","600422","600535","688626","BK0028","688114","688176","600529","688690","600276","688443","600211","600285","688617","688767","688271","688321","688166","603367","603233","688161","600488"],"gpt_icon":0},{"id":"2486971816","title":"诺泰生物11月27日主力资金流入355万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2486971816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486971816?lang=zh_cn&edition=full","pubTime":"2024-11-27 15:20","pubTimestamp":1732692009,"startTime":"0","endTime":"0","summary":"11月27日, 诺泰生物股价涨4.41%，报收54.68元，成交金额3.12亿元，换手率2.61%，振幅3.97%，量比1.46。诺泰生物今日主力资金净流入355万元，连续3日净流入，上一交易日主力净流入471万元，今日环比减少24.63%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为33.33%，平均涨幅为2.08%。该股近5个交易日上涨0.96%，主力资金累计净流入2082万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1167万元，其中净流出天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127153033a2591e50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127153033a2591e50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2486863072","title":"A股减肥药板块盘初活跃，昊帆生物涨超10%，诺泰生物、华森制药涨超4%，恒瑞医药、信立泰、百花医药等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2486863072","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486863072?lang=zh_cn&edition=full","pubTime":"2024-11-27 09:39","pubTimestamp":1732671569,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["301393","BK0187","BK0216","LU1328615791.USD","BK0028","LU2488822045.USD","BK0060","LU0405327494.USD","600721","LU1064131003.USD","BK0012","BK0183","BK0188","BK0229","BK0196","BK0102","LU0405327148.USD","159982","LU1064130708.USD","399300","BK0239","600276","002294","LU2148510915.USD","002907","688076"],"gpt_icon":0},{"id":"2486077010","title":"诺泰生物司美格鲁肽注射液Ⅲ期临床全国研究者会在宁召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2486077010","media":"新华日报财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486077010?lang=zh_cn&edition=full","pubTime":"2024-11-26 20:51","pubTimestamp":1732625472,"startTime":"0","endTime":"0","summary":"新华日报财经讯 近日，诺泰生物与博济医药共同组织的司美格鲁肽注射液Ⅲ期临床研究者会在南京成功召开。诺泰生物董事长童梓权介绍，司美格鲁注射液Ⅲ期临床项目复杂而严谨，需要多方通力合作，不断完善和优化项目方案。童梓权表示，希望司美格鲁肽注射液Ⅲ期临床项目高效率、高质量地完成，以期早日申报上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126205526abe08dd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126205526abe08dd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2485284783","title":"诺泰生物跌5% 3券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2485284783","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485284783?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:55","pubTimestamp":1732258500,"startTime":"0","endTime":"0","summary":"11月22日，诺泰生物股价大幅下跌，截至14点55分，诺泰生物下跌5.00%，报52.03元/股，成交2.14亿元，换手率1.82%。资金动向截止发稿，诺泰生物获得主力净流出1006万元，其中超大单流入166万元，大单流出1171万元。主营业务及业绩诺泰生物公司主营业务为多肽药物及小分子化药进行自主研发与定制研发生产。最新财报显示，今年三季报，诺泰生物实现营业收入12.52亿元，同比增长76.51%，净利润为3.50亿元，同比增长281.90%，基本每股收益为1.62元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122150913abd6aa1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122150913abd6aa1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2484509265","title":"概念掘金 | 司美格鲁肽减肥药正式在中国上市，多家电商平台已上线","url":"https://stock-news.laohu8.com/highlight/detail?id=2484509265","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484509265?lang=zh_cn&edition=full","pubTime":"2024-11-17 14:35","pubTimestamp":1731825344,"startTime":"0","endTime":"0","summary":"市场前景广阔","market":"hk","thumbnail":"https://img3.gelonghui.com/06664-7e9dde8e-9f54-49fb-a50c-81a04f916999.jpg?guru_height=853&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/06664-7e9dde8e-9f54-49fb-a50c-81a04f916999.jpg?guru_height=853&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1336126","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0154236417.USD","BK0132","603456","BK0196","LU1093756168.USD","688076","BK0114","BK4585","BK0201","BK0183","LU1064130708.USD","BK0028","LU1328615791.USD","01801","BK4007","LU1093756325.SGD","BK0239","300003","600276","BK0077","LU2488822045.USD","BK0060","BK0012","BK4532","BK0070","LU0405327148.USD","688117","IE00BKVL7J92.USD","BK0042","LU0405327494.USD","LU1064131003.USD","NVO","BK0113","002821","BK0188","IE00BZ1G4Q59.USD","300199","BK0251","LU2148510915.USD","BK4588"],"gpt_icon":1},{"id":"2482071638","title":"诺泰生物大幅上涨 生物医药产业蓬勃发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2482071638","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482071638?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:21","pubTimestamp":1731378060,"startTime":"0","endTime":"0","summary":"11月12日，诺泰生物股价大幅上涨，截至10点21分，诺泰生物上涨5.03%，报59.09元/股，成交3.22亿元，换手率2.53%。资金动向截止发稿，诺泰生物获得主力净流入5106万元，其中超大单流入2896万元，大单流入2209万元。主营业务及业绩诺泰生物公司主营业务为多肽药物及小分子化药进行自主研发与定制研发生产。最新财报显示，今年三季报，诺泰生物实现营业收入12.52亿元，同比增长76.51%，净利润为3.50亿元，同比增长281.90%，基本每股收益为1.62元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112102158abb7b4ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112102158abb7b4ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","161726","399441","BK0239"],"gpt_icon":0},{"id":"2482124279","title":"11月11日诺泰生物涨7.04%，南方医药保健灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482124279","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482124279?lang=zh_cn&edition=full","pubTime":"2024-11-11 16:09","pubTimestamp":1731312549,"startTime":"0","endTime":"0","summary":"证券之星消息，11月11日诺泰生物涨7.04%，收盘报56.26元，换手率5.87%，成交量12.9万手，成交额7.05亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共56家，其中持有数量最多的公募基金为南方医药保健灵活配置混合A。南方医药保健灵活配置混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100019591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2482279486","title":"诺泰生物涨7.04%，国金证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2482279486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482279486?lang=zh_cn&edition=full","pubTime":"2024-11-11 16:09","pubTimestamp":1731312540,"startTime":"0","endTime":"0","summary":"今日诺泰生物（688076）涨7.04%，收盘报56.26元。2024年10月23日，国金证券研究员赵海春,袁维发布了对诺泰生物的研报《多肽发力持续，前三季度净利润同比增3倍》，该研报对诺泰生物给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为76.59%。此外，民生证券研究员王班,乔波耀，东海证券研究员杜永宏,伍可心近期也对该股发布了研报，同样给出“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为广发证券的方程嫣、罗佳荣。诺泰生物（688076）个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100019587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688076"],"gpt_icon":0},{"id":"2482227669","title":"诺泰生物11月11日收涨7.04% 主力资金逆市抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2482227669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482227669?lang=zh_cn&edition=full","pubTime":"2024-11-11 15:21","pubTimestamp":1731309706,"startTime":"0","endTime":"0","summary":"11月11日, 诺泰生物股价涨7.04%，报收56.26元，成交金额7.05亿元，换手率5.87%，振幅9.97%，量比1.59。诺泰生物今日主力资金净流出3827万元，上一交易日主力净流入4983万元。该股近5个交易日上涨13.43%，主力资金累计净流入27万元；近20日主力资金累计净流出8138万元，其中净流出天数为14日。净流出前三个股分别为爱尔眼科、美年健康、诺泰生物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111153935a22bc037&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111153935a22bc037&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2482226841","title":"诺泰生物大幅上涨 青海省医保局调整检验类项目价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2482226841","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482226841?lang=zh_cn&edition=full","pubTime":"2024-11-11 13:10","pubTimestamp":1731301817,"startTime":"0","endTime":"0","summary":"11月11日，诺泰生物股价大幅上涨，截至13点10分，诺泰生物上涨5.02%，报55.20元/股，成交4.16亿元，换手率3.53%。资金动向截止发稿，诺泰生物获得主力净流入1450万元，其中超大单流入1391万元，大单流入58万元。主营业务及业绩诺泰生物公司主营业务为多肽药物及小分子化药进行自主研发与定制研发生产。最新财报显示，今年三季报，诺泰生物实现营业收入12.52亿元，同比增长76.51%，净利润为3.50亿元，同比增长281.90%，基本每股收益为1.62元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111131109abb4bfa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111131109abb4bfa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688076"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-05-20","address":"江苏省连云港市连云区经济技术开发区临浦路28号","stockEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0288},{"period":"3month","weight":-0.0322},{"period":"6month","weight":-0.3225},{"period":"1year","weight":0.2282},{"period":"ytd","weight":0.1667}],"companyName":"江苏诺泰澳赛诺生物制药股份有限公司","boardCode":"AI0027","perCapita":"18852股","boardName":"医药制造业","registeredCapital":"21977万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":" 江苏诺泰澳赛诺生物制药股份有限公司是一家聚焦多肽药物及小分子化药进行自主研发与定制研发生产相结合的生物医药企业。公司的主要产品为阿托伐他汀钙片、氨氯地平阿托伐他汀钙片、利拉鲁肽、司美格鲁肽、苯甲酸阿格列汀、比伐芦定、依替巴肽、醋酸兰瑞肽、醋酸奥曲肽、磷酸奥司他韦、胸腺法新、GLP-1/GIP/GCG受体多靶点激动剂1类新药、氟维司群。","serverTime":1734681088557,"listedPrice":15.57,"stockholders":"11658人(较上一季度减少1.69%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺泰生物(688076)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺泰生物(688076)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺泰生物,688076,诺泰生物股票,诺泰生物股票老虎,诺泰生物股票老虎国际,诺泰生物行情,诺泰生物股票行情,诺泰生物股价,诺泰生物股市,诺泰生物股票价格,诺泰生物股票交易,诺泰生物股票购买,诺泰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺泰生物(688076)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺泰生物(688076)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}